URL has been copied successfully!
WASHINGTON — Trump administration officials last Friday touted the success of their drug pricing policy, saying every U.S. state had agreed to participate in a federal initiative designed to provide lower prices to state Medicaid programs.
“It’s such a good deal that every state realized they need to take it,” Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, said at a White House event.
But officials in several states told STAT they’re actually still undecided on whether to participate — even if they did technically apply — and others are still trying to determine whether the federal initiative, called the GENEROUS model, actually offers a better deal than what they get through existing rebates from drugmakers.
Please follow us:
